About Swift

Swift Biosciences develops and commercializes NGS Library Preparation Kits that enable technologies for genomics, translational, and clinical research. Our proprietary technologies expand the range of sample inputs to extend the applications of next-generation sequencing (NGS).  Swift Library Kits are designed to maximize data output, provide the most comprehensive coverage available on the market and reduce sequencing costs.  Our products are designed to facilitate library normalization and to analyze DNA and RNA samples for applications including Liquid Biopsy (circulating, cell-free DNA), Methylation Sequencing, Whole Genome, Exome and Transcriptome Sequencing as well as Chromatin studies, from low input quantities and from Formalin-Fixed, Paraffin-Embedded samples.  The mission of Swift is to provide research tools for long term improvements in the health of individuals and their communities all around the world, specifically in the fight against cancer and understanding the complexities of inherited diseases.  The tools developed in our efforts are directly applicable to research in agrigenomics, biotechnology, metagenomics, and the pharmaceutical industry.

Swift BioSciences Team

Swift Biosciences entered the Next-Generation Sequencing Market in 2013 and enjoys the collaboration of renowned scientists with a history of successful businesses and the support of experienced life science investors. Our innovation pipeline, developed by our growing team of talented scientists, has generated multiple validated products for translational research across the genomics landscape.

BOARD OF DIRECTORS

dan kidle

DAN KIDLE

Chairman

Nathan Wood

NATHAN WOOD

President and
Chief Executive Officer

Jack Ball

Jack Ball

Director

Linda Tufts, Director, Swift BioSciences

Linda Tufts

Director

Mark Lewis

Mark L. Lewis

Director

Dan Watkins

Dan Watkins, PhD

Director

Walter Young, Director, Swift BioSciences

Walter Young

Director

Management Team

The Swift Biosciences team combines excellence in science with superior business skills to deliver first-in-class library preparation for next-generation sequencing. The considerable experience, expertise, and commitment of our exceptional leaders and colleagues enable us to extend our impact and achieve success.

Nathan Wood

Nathan Wood

President and Chief Executive Officer

Vladimir Makarov, PhD, Chief Scientific Officer, Swift BioSciences

Vladimir Makarov, PhD

Chief Scientific Officer

James Militello, Chief Financial Officer and Treasurer

James Militello

Chief Financial Officer and Treasurer

Laurie Kurihara

Laurie Kurihara, PhD

Senior Vice President, Product Development

Camille Cappello Vice President, Global Marketing

Camille Cappello

Vice President, Global Marketing

Christine Haakenson

Christine Haakenson, PhD

Senior Vice President of Operations

Sales Team

Kellie Feck

Vice President of Sales, North America

410.292.6878

[email protected]

Steven Riedmuller

Chief Commercial Officer

301.305.2578

[email protected]

North America

Nada Abdel-Magid

Senior Business Development Manager, Mid-Atlantic

215.460.0619

[email protected]

Chris Cook

Senior Business Development Manager, South

470.350.7919

[email protected]

Ian Silber

Team Sales Lead, Midwest & West

708.310.1965

[email protected]

William Love

Senior Business Development Manager, Northeast

617.320.0441

[email protected]

Jerell Aguila, PhD

Senior Business Development Manager, West

702.353.0808

[email protected]

Matthew Aspinwall

Senior Business Development Manager, Pacific Northwest

805.807.5112

[email protected]

International

Gerardas Dambrauskas, PhD

Vice President of Commercial Operations, EMEA

London, UK

447903777875

[email protected]

Jean-Marc Terral

VP of Commercial Operations, APAC

619.739.1051

[email protected]

Mengmeng Lin

Field Applications Specialist, APAC

+86 13537879824

[email protected]